Author
Listed:
- Marjolein Drent
(Maastricht University
St. Antonius Hospital
ILD Care Foundation)
- Petal A. Wijnen
(St. Antonius Hospital
ILD Care Foundation
Maastricht University Medical Centre)
- Naomi T. Jessurun
(ILD Care Foundation
Netherlands Pharmacovigilance Centre Lareb)
- Ankie M. Harmsze
(St. Antonius Hospital
St. Antonius Hospital)
- Otto Bekers
(Maastricht University
Maastricht University Medical Centre)
- Aalt Bast
(Maastricht University
ILD Care Foundation)
Abstract
Background Pulmonary toxicity has been associated with drug use. This is often not recognized in clinical practice, and underestimated. Objective We aimed to establish whether polymorphisms in certain genes corresponding with a metabolic pathway of drug(s) used are associated with pulmonary toxicity in patients with suspected drug-induced interstitial lung disease (DI-ILD). Methods This retrospective observational study explored genetic variations in three clinically relevant cytochrome P450 (CYP) iso-enzymes (i.e., CYP2D6, CYP2C9, and CYP2C19) in a group of patients with a fibroticinterstitial lung disease, either non-specific interstitial pneumonia (n = 211) or idiopathic pulmonary fibrosis (n = 256), with a suspected drug-induced origin. Results Of the 467 patients, 79.0% showed one or more polymorphisms in the tested genes accompanied by the use of drug(s) metabolized by a corresponding affected metabolic pathway (60.0% poor metabolizers and/or using two or more drugs [likely DI-ILD], 37.5% using three or more [highly likely DI-ILD]). Most commonly used drugs were statins (63.1%) with a predominance among men (69.4 vs 47.1%, p
Suggested Citation
Marjolein Drent & Petal A. Wijnen & Naomi T. Jessurun & Ankie M. Harmsze & Otto Bekers & Aalt Bast, 2024.
"Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease,"
Drug Safety, Springer, vol. 47(4), pages 355-363, April.
Handle:
RePEc:spr:drugsa:v:47:y:2024:i:4:d:10.1007_s40264-024-01400-0
DOI: 10.1007/s40264-024-01400-0
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:47:y:2024:i:4:d:10.1007_s40264-024-01400-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.